Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


Breath Diagnostics

Dr Marc van der Schee and Dr Theodore W Wilson at Owlstone Medical present how non-invasive biomarkers generated from volatile organic compounds in respiration are suitable for clinical applications in identifying patient populations and improving treatment efficacy.

Dr Marc van der Schee and Dr Theodore W Wilson, Owlstone Medical (April 2017)

Keywords: Asthma Biomarkers Breath Volatile organic compounds

    View full article    |    Back to Biopharma section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |